Corrigendum to ‘A chemical genetic screen identifies Aurora kinases as a therapeutic target in EGFR T790M negative, gefitinib-resistant head and neck squamous cell carcinoma (HNSCC)’

The authors added the following funding information in the Acknowledgement.

JLL was supported in part by the Agency for Science, Technology and Research (A*STAR) and by the National Research Foundation Competitive Research Programme grant awarded to RD as co-PI and Prof. Vinay Tergaonkar as PI (NRF-CRP17-2017-02). The funding bodies had no direct role in study design, data collection, data analyses, or interpretation, however we thank them for their financial support.